Pintels Global DNA Diagnostics Analytics

Innovations, Intellectual Property in Pintels DNA Diagnostics Analytics

Diagnostics is important technology sector of life sciences industry vertical. DNA Diagnostics industry encompasses broad array of technologies. Based on product type, DNA diagnostics can be categoried as instruments, reagents, services and software.

From technology standpoint Global DNA diagnostics landscape can be categorized as PCR, microarray, in-situ hybridization and sequencing technology.

Global DNA Diagnostics application markets pan across infectious diseases - Hepatitis B, Hepatitis C, HIV, TB; oncology, myogenic disorder, prenatal diagnostics and pre-implantation diagnostics. Pintels global DNA diagnostics analytics is focused on innovation and technologies to accelerate innovations from lab to market and fast track growth. It helps you identify the wtrends and opportunities, understand the competitive landscape, gain deep insights to make right decision at right time and add value.

 

Where & How businesses can leverage DNA Diagnostics Innovations

Pintels DNA diagnostics intelligence analytics pan across multiple technology segments. These include PCR, Microarray, In-situ hybridization, sequencing technology and mass spectrometry.

Leveraging Pintels Intelligence Analytics you can get deep insights into the diagnostics technology landscape. These include - Blood, fluid, tissue testing, ortho clinical diagnostics, investing and analyzing materials, PCR, qPCR, Digital PCR, Reagents, peptides, immuno-assays and more. Pintels for clinical diagnostics provision deep insights into innovation, patent portfolios of all major companies on one side and upcoming innovation start-ups on the other end of the spectrum. Key market players in clinical diagnostics technology landscape include bio-rad laboratories, Beckman Coulter, Biomerieux, Thermo Fisher Scientific, Sysmex Corporation, Roche Diagnostics and more.